2015
DOI: 10.1002/14651858.cd009464.pub2
|View full text |Cite
|
Sign up to set email alerts
|

Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
169
0
11

Year Published

2016
2016
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 173 publications
(180 citation statements)
references
References 125 publications
0
169
0
11
Order By: Relevance
“…This research has focused primarily on a handful of the multitude of medical conditions and symptoms for which the benefits of cannabis have been proclaimed anecdotally, including muscle spasm and chronic pain (Borgelt, Franson, Nussbaum, & Wang, 2013; Harrison, Heritier, Childs, Bostwick, & Dziadzko, 2015), nausea and vomiting (Smith, Azariah, Lavender, Stoner, & Bettiol, 2015), epilepsy (Friedman & Devinsky, 2015), appetite stimulation (Gorter, 1999), cancer (Pacher, 2013), and several psychiatric disorders (e.g., post-traumatic stress disorder, anxiety, depression; Betthauser, Pilz, & Vollmer, 2015; Zlebnik & Cheer, 2016). To date, the quality of evidence supportive of cannabinoid treatment for spasticity and chronic pain has been moderate, whereas only low-quality evidence was available to support its use for nausea and vomiting and for weight gain in patients with HIV/AIDS or cancer (for a review, see Whiting et al, 2015).…”
Section: Promises Of Ediblesmentioning
confidence: 99%
“…This research has focused primarily on a handful of the multitude of medical conditions and symptoms for which the benefits of cannabis have been proclaimed anecdotally, including muscle spasm and chronic pain (Borgelt, Franson, Nussbaum, & Wang, 2013; Harrison, Heritier, Childs, Bostwick, & Dziadzko, 2015), nausea and vomiting (Smith, Azariah, Lavender, Stoner, & Bettiol, 2015), epilepsy (Friedman & Devinsky, 2015), appetite stimulation (Gorter, 1999), cancer (Pacher, 2013), and several psychiatric disorders (e.g., post-traumatic stress disorder, anxiety, depression; Betthauser, Pilz, & Vollmer, 2015; Zlebnik & Cheer, 2016). To date, the quality of evidence supportive of cannabinoid treatment for spasticity and chronic pain has been moderate, whereas only low-quality evidence was available to support its use for nausea and vomiting and for weight gain in patients with HIV/AIDS or cancer (for a review, see Whiting et al, 2015).…”
Section: Promises Of Ediblesmentioning
confidence: 99%
“…Existing studies are plagued by small sample sizes and heterogeneity in marijuana products trialed. Domestic restrictions on clinical trials that employ Schedule I controlled substances further hinder investigation on MM . This has led to more research on cannabinoid pharmaceuticals, such as dronabinol, than on MM .…”
Section: Evidence For Medical Marijuana In Cancer Carementioning
confidence: 99%
“…El sistema cannabinoide se compone de receptores cannabinoides (tipo 1 y tipo 2) y su uni贸n a sustancias cannabinoides end贸genas (endocannabinoides) 4,6,7 ; sin embargo, los cannabinoides provenientes del cannabis (fitocannabinoides) 8,9 y los elaborados artificialmente (exocannabinoides) 10 tienen la capacidad de unirse a estos receptores, activar el sistema y alterarlo a largo plazo.…”
Section: Sistema Cannabinoideunclassified
“…Desde el punto de vista de las ciencias de la salud existe la posibilidad del uso medicinal de Cannabis sativa por medio de su inhalaci贸n, el consumo de infusiones y el uso t贸pico de cremas derivadas 3,4 . No obstante, tambi茅n se ha visto que siendo una sustancia adictiva 5,6 podr铆a afectar a los individuos consumidores en aspectos como la funci贸n normal del sistema nervioso central y el proceso para la utilizaci贸n de algunos nutrientes.…”
Section: Introductionunclassified